MNMyron Nevins

Myron Nevins

*This is an algorithmically generated author record based on publicly available information.

Myron Nevins has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gas Plasma Treatment Improves Titanium Dental Implant Osseointegration—A Preclinical In Vivo Experimental Study

    by Myron Nevins, Chia-Yu Chen, Stephano Parma-Benfenati, David M. Kim

    Recent technological advancements led to the development of various plasma-based technologies for post-packaging modifications. The purpose of the present preclinical in vivo study was to assess the safety and efficacy of a novel chairside nonthermal gas plasma treatment for enhancing osseointegration of titanium implants. Six male mixed foxhounds underwent extraction of mandibular premolars and first molars, and the sockets healed for 42 days. Canine mandibles were randomized to receive either plasma-treated (test) or non-plasma-treated (control) dental implants. A total of 36 implants were placed in six animals, and they were sacrificed at 2 weeks (two animals), 4 weeks (two animals), and 6 weeks (two animals) after the implant surgery. When the radiographic analysis was performed, the changes in bone level were not statistically significant between the two groups at 2 weeks and 4 weeks. The difference became significant at 6 weeks (p = 0.016), indicating more bone loss from baseline to 6 weeks for the control group. The bone-to-implant contact (BIC) appeared to be higher for the test groups at all time points, and the BIC was significantly higher for the test group at 4 weeks (p = 0.046). In conclusion, this study underscored the potential of nonthermal plasma treatment in enhancing implant osseointegration.


  • Open Access

    Histologic Evidence of Oral and Periodontal Regeneration Using Recombinant Human Platelet-Derived Growth Factor

    by Mohamed M. Meghil, Obada Mandil, Myron Nevins, Muhammad H. A. Saleh, Hom-Lay Wang

    Human histology provides critical information on the biological potential of various regenerative protocols and biomaterials, which is vital to advancing the field of periodontal regeneration, both in research and clinical practice. Outcomes of histologic studies are particularly valuable when interpreted considering additional evidence available from pre-clinical and clinical studies. One of the best-documented growth factors areproven to have positive effects on a myriad of oral regenerative procedures is recombinant human platelet-derived growth factor—BB (rhPDGF-BB). While a systematic review of clinical studies evaluating rhPDGF in oral regenerative procedures has been recently completed, a review article that focuses on the histologic outcomes is needed. Hence, this communication discusses the histologic effects of rhPDGF-BB on oral and periodontal regenerative procedures, including root coverage and soft tissue augmentation, intrabony defects, furcation defects, peri-implant bone augmentation, and guided bone regeneration. Studies from 1989 to 2022 have been included in this review.


  • Equine-Derived Bone Mineral Matrix for Maxillary Sinus Floor Augmentation: A Clinical, Radiographic, Histologic, and Histomorphometric Case Series

    by Myron Nevins, Friedhelm Heinemann, Ulrich W Janke, Teresa Lombardi, David Nisand, Isabella Rocchietta, Giacomo Santoro, Peter Schupbach, David M Kim

    Myron Nevins, DDS/Friedhelm Heinemann, DDS/Ulrich W. Janke, DDS/Teresa Lombardi, DDS/David Nisand, DDS/Isabella Rocchietta, DDS/Giacomo Santoro, DDS/Peter Schupbach, PhD/David M. Kim, DDS, DMSc: The objective of this proof-of-principle multicenter case series was to examine the bone regenerative potential of a newly introduced equine-derived bone mineral matrix (Equimatrix) to provide human sinus augmentation for the purpose of implant placement in the posterior maxilla. There were 10 patients requiring 12 maxillary sinus augmentations enrolled in this study. Histologic results at 6 months demonstrated abundant amounts of vital new bone in intimate contact with residual graft particles. Active bridging between residual graft particles with newly regenerated bone was routinely observed in intact core specimens. A mean value of 23.4% vital bone formation was observed at 6 months. This compared favorably with previous results using xenografts to produce bone in the maxillary sinus for the purpose of dental implant placement. Both the qualitative and quantitative results of this case series suggest comparable bone regenerative results at 6 months to bovine-derived xenografts. (Int J Periodontics Restorative Dent 2013;33:483?489. doi: 10.11607/prd.1728.)


  • Maintaining Interimplant Crestal Bone Height Via a Combined Platform- Switched, Laser-Lok Implant/Abutment System: A Proof-of-Principle Canine Study

    by Myron Nevins, Marc Nevins, Luca Gobbato, Hyo-Jung Lee, Chin-Wei Wang, David M Kim

    Myron Nevins, DDS/Marc Nevins, DMD, MMSc/Luca Gobbato, DDS, MS/Hyo-Jung Lee, DDS, PhD/Chin-Wei Wang, DDS/David M. Kim, DDS, DMSc: Interimplant papillae are critical for achieving esthetic implant-supported restorations in the maxillary esthetic zone. Stable papillary anatomy, however, depends upon a stable volume of underlying crestal bone for support. Multiple studies have documented a critical interimplant distance of 3 mm under which crestal bone resorption occurs. This preclinical proofof- principle canine study examines a novel implant-abutment system design, combining platform switching with precisely configured laserablated abutment and implant microgrooves to maintain interimplant crestal bone at interimplant distances of 2 and 4 mm. Results of this initial preclinical study suggest that it is possible through precise implant/ abutment design modifications to place adjacent implants at distances of 2 to 4 mm without inducing subpapillary crestal bone loss. (Int J Periodontics Restorative Dent 2013;33:261?267. doi: 10.11607/prd.1773)


  • A 42‐Year Observation of Traditional Periodontal Therapy Supplemented by Dental Implants

    by Myron Nevins, Jeffrey Dornbush, Samuel Koo, Massimo Depaoli, David M. Kim

    Introduction: Periodontal disease can be successfully treated and maintained for an extensive period. A small category of patients demonstrates aggressive periodontitis (previously known as refractory periodontitis), which does not respond appropriately to the traditional therapy even when the patient's compliance is excellent.Case Presentation: This case report presents a long‐term observation of dental implants replacing teeth with a compromised maxillary periodontium. Implants were placed initially in 1989 and 1993 to supplement some remaining teeth. These implants continue to function after 23 years. The maxillary central incisors were fractured in 2005 and replaced with two platform‐switched implants. This area has demonstrated crestal stability after 7 years.Conclusion: A long‐term observation of this patient demonstrated that dental implants are successful in periodontally compromised patients, and the crestal bone remained stable around the platform‐switched implants.

  • Platelet‐Derived Growth Factor Promotes Periodontal Regeneration in Localized Osseous Defects: 36‐Month Extension Results From a Randomized, Controlled, Double‐Masked Clinical Trial

    by Myron Nevins, Richard T. Kao, Michael K. McGuire, Pamela K. McClain, James E. Hinrichs, Bradley S. McAllister, Michael S. Reddy, Marc L. Nevins, Robert J. Genco, Samuel E. Lynch, et al.

    Background: Recombinant human platelet‐derived growth factor (rhPDGF) is safe and effective for the treatment of periodontal defects in short‐term studies up to 6 months in duration. We now provide results from a 36‐month extension study of a multicenter, randomized, controlled clinical trial evaluating the effect and long‐term stability of PDGF‐BB treatment in patients with localized severe periodontal osseous defects.Methods: A total of 135 participants were enrolled from six clinical centers for an extension trial. Eighty‐three individuals completed the study at 36 months and were included in the analysis. The study investigated the local application of β‐tricalcium phosphate scaffold matrix with or without two different dose levels of PDGF (0.3 or 1.0 mg/mL PDGF‐BB) in patients possessing one localized periodontal osseous defect. Composite analysis for clinical and radiographic evidence of treatment success was defined as percentage of cases with clinical attachment level (CAL) ≥2.7 mm and linear bone growth (LBG) ≥1.1 mm.Results: The participants exceeding this composite outcome benchmark in the 0.3 mg/mL rhPDGF‐BB group went from 62.2% at 12 months, 75.9% at 24 months, to 87.0% at 36 months compared with 39.5%, 48.3%, and 53.8%, respectively, in the scaffold control group at these same time points (P Conclusion: PDGF‐BB in a synthetic scaffold matrix promotes long‐term stable clinical and radiographic improvements as measured by composite outcomes for CAL gain and LBG for patients possessing localized periodontal defects (ClinicalTrials.gov no. CT01530126).


    • 1 December 2012
      • Vol. 32  (6) , 637-45

    The impact of bone compression on bone-to-implant contact of an osseointegrated implant: a canine study.

    by Myron Nevins, Marc L Nevins, Peter Schupbach, Joseph Fiorellini, Zhao Lin, David M Kim

    The dental community's interest in early loading of endosseous implants provides the stimulation to test the ability of modified implant designs as well as surgical techniques to enhance the establishment and maintenance of implant stability. This preclinical canine study examined this potential by implementing several implant design and surgical technique modifications to an existing tapered implant system. The design and site preparation changes were intended to induce different compression states on the native bone, hypothetically affecting the primary stability and the rate and extent of osseointegration. The outcomes of the modifications were evaluated using resonance frequency analysis, radiographic analysis, light microscopy, and histomorphometric measurements. Three compression scenarios were tested, with each demonstrating excellent clinical, radiographic, and histologic results throughout the evaluation period. However, the scenario intended to induce a moderate degree of compression provided the best overall results, supporting its use in early loading protocols.